Optimization Of Glycaemic Control And Prevention Of Hypoglycaemia And Microvascular Complications In Children And Adolescents With Type 1 Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$452,051.00
Summary
Type 1 diabetes is a complex life-long disease that has onset in the young and carries a significant burden. Good management is crucial as it helps prevent the serious long term complications of the disease such as blindness and kidney disease. Low blood glucose or hypoglycaemia is a common side effect of insulin treatment. This research aims to explore ways to treat the disease more effectively, prevent hypoglycaemia and other diabetes complications and in so doing improve the outcomes for youn ....Type 1 diabetes is a complex life-long disease that has onset in the young and carries a significant burden. Good management is crucial as it helps prevent the serious long term complications of the disease such as blindness and kidney disease. Low blood glucose or hypoglycaemia is a common side effect of insulin treatment. This research aims to explore ways to treat the disease more effectively, prevent hypoglycaemia and other diabetes complications and in so doing improve the outcomes for young people with diabetes.Read moreRead less
Developing Clinical Islet Transplantation For Type 1 Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$387,337.00
Summary
This fellowship will provide me the opportunity to advance islet transplantation as a curative treatment for people with type 1 diabetes. The ultimate goal is to use cell-based therapy to achieve insulin independence for all people with type 1 diabetes. It aims to do this by developing a collaborative network between scientists and clinicians to advance human islet transplantation as a treatment for type 1 diabetes and to develop genetically engineered pig cells as a novel source of insulin prod ....This fellowship will provide me the opportunity to advance islet transplantation as a curative treatment for people with type 1 diabetes. The ultimate goal is to use cell-based therapy to achieve insulin independence for all people with type 1 diabetes. It aims to do this by developing a collaborative network between scientists and clinicians to advance human islet transplantation as a treatment for type 1 diabetes and to develop genetically engineered pig cells as a novel source of insulin producing cellsRead moreRead less